Seven Cases of Breast Cancer Recurrence Limited to the Central Nervous System without Other Visceral Metastases
スポンサーリンク
概要
- 論文の詳細を見る
- 2000-04-25
著者
-
NARABAYASHI Masaru
National Cancer Center Hospital
-
WATANABE Toru
National Cancer Center Hospital
-
FUKUTOMI Takashi
National Cancer Center Hospital
-
AKASHI-TANAKA Sadako
Department of Surgical Oncology, National Cancer Center Hospital
-
Nakata Masanobu
Division Of Oncology And Hematology National Cancer Center Hospital East
-
Fukutomi T
National Cancer Center Hospital
-
Fukutomi Takashi
Departmnet Of Surgery National Cancer Center Hospital
-
Fukutomi Takashi
Division Of Surgery National Cancer Center Hospital
-
HIGASHI Hisato
The Department of Surgical Oncology, National Cancer Center Hospital
-
FUKUTOMI Takashi
The Department of Surgical Oncology, National Cancer Center Hospital
-
WATANABE Toru
The Department of Medical Oncology, National Cancer Center Hospital
-
ADACHI Isamu
The Department of Medical Oncology, National Cancer Center Hospital
-
NARABAYASHI Masaru
The Department of Medical Oncology, National Cancer Center Hospital
-
SHIBUI Soichirou
The Department of Surgical Oncology, National Cancer Center Hospital
-
HOKAMURA Nobukazu
The Department of Surgical Oncology, National Cancer Center Hospital
-
AKASHI-TANAKA Sadako
The Department of Surgical Oncology, National Cancer Center Hospital
-
Watanabe T
Hematology Division National Cancer Center Hospital
-
Akashi-tanaka Sadako
Division Of Breast Surgery National Cancer Center Hospital
-
Tanaka Sadako
Division Of Breast Surgery National Cancer Center Hospital
-
Adachi Isamu
The Department Of Medical Oncology National Cancer Center Hospital
-
Higashi Hisato
The Department Of Surgical Oncology National Cancer Center Hospital
-
Fukutomi Takashi
Department Of Surgical Oncology National Cancer Center Research Institute And Hospital
-
Akashi-tanaka Sadako
Department Of Surgical Oncology National Cancer Center Hospital
-
Shibui Soichirou
The Department Of Surgical Oncology National Cancer Center Hospital
-
Hokamura Nobukazu
The Department Of Surgical Oncology National Cancer Center Hospital
-
Watanabe Toru
Hematology And Stem Cell Transplantation Division National Cancer Center Hospital
-
Narabayashi Masaru
The Department Of Medical Oncology National Cancer Center Hospital
関連論文
- Histological and immunophenotypic changes in 59 cases of B-cell non-Hodgkin's lymphoma after rituximab therapy
- Progressive multifocal leukoencephalopathy in a patient with B-cell lymphoma during rituximab-containing chemotherapy : case report and review of the literature
- Stromal cells in bone marrow play important roles in pro-inflammatory cytokine secretion causing fever following bortezomib administration in patients with multiple myeloma
- Diffuse large B-cell lymphoma after transformation from low-grade follicular lymphoma : morphological, immunohistochemical, and FISH analyses
- Nocardia exalbida brain abscess in a patient with follicular lymphoma
- Phase I and II pharmacokinetic and pharmacodynamic study of the proteasome inhibitor bortezomib in Japanese patients with relapsed or refractory multiple myeloma
- Prognostic analysis and a new risk model for Hodgkin lymphoma in Japan
- Phase I Study of Intravenous PSC-833 and Doxorubicin: Reversal of Multidrug Resistance
- Cross-sectional analysis of germline BRCA1 and BRCA2 mutations in Japanese patients suspected to have hereditary breast/ovarian cancer
- Immunoreaction at 43 kDa with Anti-ubiquitin Antibody in Breast Neoplasms
- Phase I study of radioimmunotherapy with an anti-CD20 murine radioimmunoconjugate (^Y-ibritumomab tiuxetan) in relapsed or refractory indolent B-cell lymphoma
- t(11 ; 18)-Bearing Pulmonary Mucosa-Associated Lymphoid Tissue Lymphoma Responding to Cladribine
- Two Entities of Precursor T-Cell Lymphoblastic Leukemia/Lymphoma Based on Radiologic and Immunophenotypic Findings
- Primary Mediastinal Large B-Cell Lymphoma : A Single-Institution Clinical Study in Japan
- EBV-Positive Burkitt Lymphoma as a Late-Onset Posttransplantion Lymphoproliferative Disorder after Allogeneic Stem Cell Transplantation
- Primary Hepatic Low-Grade B-Cell Lymphoma of the Mucosa-Associated Lymphoid Tissue Type : A Case Report and Review of the Literature
- Japanese phase II study of ^Y-ibritumomab tiuxetan in patients with relapsed or refractory indolent B-cell lymphoma
- Phase III study to evaluate the use of high-dose chemotherapy as consolidation of treatment for high-risk postoperative breast cancer : Japan Clinical Oncology Group study, JCOG 9208
- Randomized phase II study of concurrent and sequential rituximab and CHOP chemotherapy in untreated indolent B-cell lymphoma
- Extragonadal germ cell tumors in Japan
- B-cell lymphoma accompanying monoclonal macroglobulinemia with features suggesting marginal zone B-cell lymphoma
- A Phase II Study of VEPA/FEPP Chemotherapy for Aggressive Lymphoma in Elderly Patients : Japan Clinical Oncology Group Study JCOG9203
- High proportion of missense mutations of the BRCA1 and BRCA2 genes in Japanese breast cancer families
- Bilateral Breast Cancer in a Patient with a Strong Family History of Cancer; Analysis of p53 Germ Line Mutations
- Bilateral Nonpalpable Breast Carcinomas in a Patient with BRCA2 Germ Line Mutation and Past History of Osteosarcoma
- Insulin-Dependent Diabetic Mastopathy : A Case Report
- CD44 Variant Isoform Expression and Breast Cancer Prognosis
- Clinicopathological Characteristics of Primary Breast Cancer in Older Geriatric Women: A Study of 39 Japanese Patients over 80 Years Old
- The Role of Computed Tomography in the Selection of Breast Cancer Treatment
- Nodular Mucinosis of the Breast : A Case Report with Clinical and Imaging Findings
- Histological Grade, p53, HER2 and Hormone Receptor Status of Synchronous Bilateral Breast Carcinoma
- Concordance in Pathological Response to Neoadjuvant Chemotherapy between Invasive and Noninvasive Components of Primary Breast Carcinomas
- Histological and Immunohistochemical Analysis of Apocrine Breast Carcinoma
- Detectin of numerical alterations of chromosome 1 in cytopathological specimens of breast tumors by chromogen in situ hybridization
- Two Special Types of Breast Cancer Presenting as Progressive Disease after Neoadjuvant Chemotherapy with Docetaxel plus Doxorubicin
- Diabetic Mastopathy: A Case Report with Reference to the Findings of Enhanced Computed Tomography
- Multicentricity and histopathological background features of familial bfeast cancer stratified by menopausal status
- A Case of Malignant Phyllodes Tumor of the Breast with Osteosarcomatous Features
- Contrast-Enhanced Computed Tomography for Diagnosing the Intraductal Component and Small Invasive Foci of Breast Cancer
- Concordance in judgments among c-erbB-2 (HER2neu) overexpression detected by two immunohistochemical tests and gene amplification detected by Southern blot hybridization in breast carcinoma
- Treatment of Noninvasive Carcinoma: Fifteen-Year Results at the National Cancer Center Hospital in Tokyo
- Evaluation of Histopathological Criteria for Identifying Node-negative Breast Cancer with High Risk of Early Recurrence in the NSAS-BC Protocol Study
- Preferential Occurrence of Breast Carcinomas with Loss of Chromosome 16q and der(16)t(1;16)/der(1;16) in Middle-aged Patients with Hyperplasia of Mammary Glands
- Seven Cases of Breast Cancer Recurrence Limited to the Central Nervous System without Other Visceral Metastases
- Breast Carcinoma with Osteoclast-like Giant Cells: A Case Report and Review of the Japanese Literature
- Histological Factors Associated with Initial Bone Metastasis of Invasive Ductal Carcinoma of the Breast
- Polyvinylalcohol Microgel
- Evaluation of HER2 Status: For the Treatment of Metastatic Breast Cancers by Humanized Anti-HER2 Monoclonal Antibody (Trastuzumab) (Pathological Committee for Optimal Use of Trastuzumab)
- Hematopoietic stem cell transplantation for therapy-related myelodysplastic syndrome and acute leukemia : a single-center analysis of 47 patients
- Potential efficacy of the oral histone deacetylase inhibitor vorinostat in a phase I trial in follicular and mantle cell lymphoma
- Apocrine Carcinoma of the Breast: Clinicopathological Analysis and Histological Subclassification of 12 Cases
- Japanese Late-Onset Breast Cancer Families: Their Clinicopathological Characteristics and Absence of BRCA1 and BRCA2 Germline Mutations
- Local Recurrence after Conservative Surgery without Postoperative Radiation for Pure Tubular Carcinoma of the Breast:A Case Report with Reference to Multifocality of Tubular Carcinoma
- Clinical Use of Contrast-Enhanced Computed Tomography for Decision Making in Breast Conserving Surgery
- BRCA1 and BRCA2 Germline Mutations in Japanese with Hereditary Breast Cancer Families
- Clinicopathological Characteristics of Non-palpable Breast Cancer Presenting as an Axillary Mass
- Phase II study of oral fludarabine in combination with rituximab for relapsed indolent B-cell non-Hodgkin lymphoma
- Phase I/II and pharmacokinetic study of cladribine with 2-h infusion in Japanese patients with relapsed indolent B-cell lymphoma mostly pretreated with rituximab
- Pharmacodynamic Modeling of the Entire Time Course of Leukopenia after a 3-Hour Infusion of Paclitaxel
- A Case of Dermatofibrosarcoma Protuberans in the Skin over the Breast
- Diagnostic Value of Enhanced Computed Tomography in the Detection of the Widely Spreading Intraductal Component of Breast Cancer: Case Reports
- Higher Level of P-glycoprotein Expression in Human Breast Cancer Cells after Radiation Therapy
- Tumor-associated Fever in Recurrent Breast Cancer with Liver Metastases
- A quantitative model using mean and standard deviation for evaluation of interobserver agreement in nuclear atypia scoring of breast carcinomas in a protocol study
- Modified cyclophosphamide, vincristine, doxorubicin, and methotrexate (CODOX-M)/ifosfamide, etoposide, and cytarabine (IVAC) therapy with or without rituximab in Japanese adult patients with Burkitt lymphoma (BL) and B cell lymphoma, unclassifiable, with
- Randomized phase II study of concurrent and sequential combinations of rituximab plus CHOP (cyclophosphamide, doxorubicin, vincristine and prednisolone) chemotherapy in untreated indolent B-cell non-Hodgkin lymphoma : 7-year follow-up results
- Multicenter phase II study of bendamustine for relapsed or refractory indolent B-cell non-Hodgkin lymphoma and mantle cell lymphoma
- Phase I and pharmacokinetic study of bendamustine hydrochloride in relapsed or refractory indolent B-cell non-Hodgkin lymphoma and mantle cell lymphoma
- Phase I study of inotuzumab ozogamicin (CMC-544) in Japanese patients with follicular lymphoma pretreated with rituximab-based therapy
- Phase I study of LY2469298, an Fc-engineered humanized anti-CD20 antibody, in patients with relapsed or refractory follicular lymphoma
- Feasibility and pharmacokinetic study of bendamustine hydrochloride in combination with rituximab in relapsed or refractory aggressive B cell non-Hodgkin's lymphoma